CO5650237A2 - Procedimiento de sintesis selectiva de drivados de 2-amino-5-trifluorometil-pirimidina en presencia de un acido de lewis - Google Patents
Procedimiento de sintesis selectiva de drivados de 2-amino-5-trifluorometil-pirimidina en presencia de un acido de lewisInfo
- Publication number
- CO5650237A2 CO5650237A2 CO06018320A CO06018320A CO5650237A2 CO 5650237 A2 CO5650237 A2 CO 5650237A2 CO 06018320 A CO06018320 A CO 06018320A CO 06018320 A CO06018320 A CO 06018320A CO 5650237 A2 CO5650237 A2 CO 5650237A2
- Authority
- CO
- Colombia
- Prior art keywords
- lewis acid
- group
- pyrimidine
- amine
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Abstract
1.- Un método de preparar un compuesto de la fórmula en la que X2 es un grupo lábil, y R3 y R4 son sustituyentes seleccionados independientemente entre el conjunto que consta de hidrógeno, un grupo aromático y un grupo alifático o tomados conjuntamente -NR3R4 pueden formar un anillo aromático o alifático de 4-11 miembros, en que el método comprende hacer reaccionar un compuesto de fórmula 10 con una amina de fórmula 3 (HNR3R4) en la presencia de un Ácido de Lewis y de una base no nucleófila para formar un compuesto de fórmula 11, en el que X1 es un grupo lábil.2.- Un método de la reivindicación 1 en el que X1 y X2 son el mismo grupo lábil o diferentes grupos lábiles, seleccionados independientemente entre el conjunto que consta de haluro, arilsulfonato, alquilsulfonato, perfluoroalquilsulfonato, arilsulfinato o alquilsulfinato.3.- Un método de la reivindicación 2 en el que X1 y X2 son iguales o diferentes y son, cada uno de ellos independientemente, haluros.4.- Un método de la reivindicación 3 en el que X1 y X2 son cloruros.5.- Un método de la reivindicación 1 en el que dicha amina, HNR3R4, es una amina aromática y se usan 0,25-10 equivalentes de un Ácido de Lewis en relación con la cantidad de pirimidina 10.6.- Un método de la reivindicación 1 en el que dicha amina, HNR3R4, es una amina aromática y se usan 0,5-3 equivalentes de un Ácido de Lewis en relación con la cantidad de pirimidina 10.7.- Un método de la reivindicación 5 en el que el Ácido de Lewis es una sal de un ion metálico seleccionado entre el conjunto que consta de iones de Zn, Mg, Sn, Ti, Al, S, Li, Ag y Cu.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50073303P | 2003-09-05 | 2003-09-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5650237A2 true CO5650237A2 (es) | 2006-06-30 |
Family
ID=34272990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO06018320A CO5650237A2 (es) | 2003-09-05 | 2006-02-23 | Procedimiento de sintesis selectiva de drivados de 2-amino-5-trifluorometil-pirimidina en presencia de un acido de lewis |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7122670B2 (es) |
| EP (1) | EP1663991B1 (es) |
| JP (1) | JP4842816B2 (es) |
| KR (1) | KR100694732B1 (es) |
| CN (1) | CN100465164C (es) |
| AR (1) | AR045557A1 (es) |
| BR (1) | BRPI0414059B8 (es) |
| CA (1) | CA2537373C (es) |
| CO (1) | CO5650237A2 (es) |
| CY (1) | CY1106370T1 (es) |
| DE (1) | DE602004004287T2 (es) |
| DK (1) | DK1663991T3 (es) |
| ES (1) | ES2276344T3 (es) |
| HK (1) | HK1091824A1 (es) |
| IL (1) | IL173363A (es) |
| MX (1) | MXPA06002552A (es) |
| NO (1) | NO334383B1 (es) |
| NZ (1) | NZ544969A (es) |
| PL (1) | PL1663991T3 (es) |
| PT (1) | PT1663991E (es) |
| RU (1) | RU2315759C2 (es) |
| TW (1) | TWI283667B (es) |
| WO (1) | WO2005023780A1 (es) |
| ZA (1) | ZA200600747B (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60331479D1 (de) * | 2002-12-20 | 2010-04-08 | Pfizer Prod Inc | Pyrimidin-derivate zur behandlung von anormalem zellwachstum |
| US20060205945A1 (en) * | 2004-05-14 | 2006-09-14 | Pfizer Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
| JP4778717B2 (ja) * | 2005-03-25 | 2011-09-21 | 富士フイルム株式会社 | 複素環式化合物の製造方法 |
| DE102007010801A1 (de) | 2007-03-02 | 2008-09-04 | Bayer Cropscience Ag | Diaminopyrimidine als Fungizide |
| BRPI0810411B8 (pt) * | 2007-04-18 | 2021-05-25 | Pfizer Prod Inc | derivados de sulfonil amida para o tratamento de crescimento celular anormal, seu sos, bem como composição farmacêutica |
| KR101294731B1 (ko) * | 2007-06-04 | 2013-08-16 | 삼성디스플레이 주식회사 | 어레이 기판, 이를 갖는 표시패널 및 이의 제조방법 |
| JP2011515372A (ja) * | 2008-03-20 | 2011-05-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 置換ピリミジン類の位置選択的製造法 |
| UY31714A (es) * | 2008-03-20 | 2009-11-10 | Boehringer Ingelheim Int | Preparación selectiva de pirimidinas sustituidas |
| DE102009006643A1 (de) | 2009-01-29 | 2010-08-05 | Saltigo Gmbh | Herstellung von halogenierten N-heteroaromatischen Polyhalogenderivaten |
| TW201100441A (en) | 2009-06-01 | 2011-01-01 | Osi Pharm Inc | Amino pyrimidine anticancer compounds |
| US8729265B2 (en) | 2009-08-14 | 2014-05-20 | Boehringer Ingelheim International Gmbh | Regioselective preparation of 2-amino-5-trifluoromethylpyrimidine derivatives |
| US8933227B2 (en) | 2009-08-14 | 2015-01-13 | Boehringer Ingelheim International Gmbh | Selective synthesis of functionalized pyrimidines |
| US9133224B2 (en) | 2010-11-29 | 2015-09-15 | OSI Pharmaceuticals, LLC | Macrocyclic kinase inhibitors |
| UY33817A (es) | 2010-12-21 | 2012-07-31 | Boehringer Ingelheim Int | ?nuevas oxindolpirimidinas bencílicas?. |
| CN103534240B (zh) | 2011-02-17 | 2015-12-09 | 癌症疗法Crc私人有限公司 | 选择性fak抑制剂 |
| ES2691673T3 (es) | 2011-02-17 | 2018-11-28 | Cancer Therapeutics Crc Pty Limited | Inhibidores de Fak |
| WO2014126954A1 (en) | 2013-02-13 | 2014-08-21 | OSI Pharmaceuticals, LLC | Regioselective synthesis of substituted pyrimidines |
| US9656970B2 (en) | 2014-05-08 | 2017-05-23 | Tosoh F-Tech, Inc. | 5-(trifluoromethyl)pyrimidine derivatives and method for producing same |
| JP6391985B2 (ja) * | 2014-05-16 | 2018-09-19 | 東ソー・ファインケム株式会社 | ２−置換−４−（２，２，２−トリフルオロエトキシ）−５−（トリフルオロメチル）ピリミジン誘導体及びその製造方法 |
| JP6391988B2 (ja) * | 2014-05-21 | 2018-09-19 | 東ソー・ファインケム株式会社 | ５−（トリフルオロメチル）ピリミジン誘導体の製造方法及び新規５−（トリフルオロメチル）ピリミジン誘導体 |
| CN108440499A (zh) * | 2018-03-22 | 2018-08-24 | 盐城师范学院 | 一种色瑞替尼及其关键中间体的制备方法 |
| CN114213339B (zh) * | 2021-12-20 | 2023-10-31 | 苏州康纯医药科技有限公司 | 一种表皮细胞生长因子受体突变抑制剂的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003030909A1 (en) * | 2001-09-25 | 2003-04-17 | Bayer Pharmaceuticals Corporation | 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer |
| DK1438053T3 (da) * | 2001-10-17 | 2008-12-08 | Boehringer Ingelheim Pharma | Pyrimidinderivater, lægemiddel indeholdende disse forbindelser, deres anvendelse og fremgangsmåder til deres fremstilling |
-
2004
- 2004-08-24 NZ NZ544969A patent/NZ544969A/en unknown
- 2004-08-24 EP EP04769170A patent/EP1663991B1/en not_active Expired - Lifetime
- 2004-08-24 BR BRPI0414059A patent/BRPI0414059B8/pt active IP Right Grant
- 2004-08-24 CA CA002537373A patent/CA2537373C/en not_active Expired - Lifetime
- 2004-08-24 WO PCT/IB2004/002744 patent/WO2005023780A1/en active IP Right Grant
- 2004-08-24 JP JP2006525198A patent/JP4842816B2/ja not_active Expired - Lifetime
- 2004-08-24 DE DE602004004287T patent/DE602004004287T2/de not_active Expired - Lifetime
- 2004-08-24 ES ES04769170T patent/ES2276344T3/es not_active Expired - Lifetime
- 2004-08-24 PL PL04769170T patent/PL1663991T3/pl unknown
- 2004-08-24 MX MXPA06002552A patent/MXPA06002552A/es active IP Right Grant
- 2004-08-24 CN CNB2004800254318A patent/CN100465164C/zh not_active Expired - Lifetime
- 2004-08-24 RU RU2006106727/04A patent/RU2315759C2/ru not_active IP Right Cessation
- 2004-08-24 KR KR1020067004428A patent/KR100694732B1/ko active IP Right Grant
- 2004-08-24 PT PT04769170T patent/PT1663991E/pt unknown
- 2004-08-24 DK DK04769170T patent/DK1663991T3/da active
- 2004-08-27 US US10/928,954 patent/US7122670B2/en active Active
- 2004-09-02 AR ARP040103140A patent/AR045557A1/es not_active Application Discontinuation
- 2004-09-03 TW TW093126748A patent/TWI283667B/zh active
-
2006
- 2006-01-25 IL IL173363A patent/IL173363A/en active IP Right Grant
- 2006-01-26 ZA ZA200600747A patent/ZA200600747B/xx unknown
- 2006-02-23 CO CO06018320A patent/CO5650237A2/es not_active Application Discontinuation
- 2006-04-03 NO NO20061509A patent/NO334383B1/no unknown
- 2006-11-09 HK HK06112349.7A patent/HK1091824A1/xx unknown
-
2007
- 2007-03-12 CY CY20071100341T patent/CY1106370T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5650237A2 (es) | Procedimiento de sintesis selectiva de drivados de 2-amino-5-trifluorometil-pirimidina en presencia de un acido de lewis | |
| MX2010008101A (es) | Derivados de indol 2-carboxamidas y de azaindol 2-carboxamidas sustituidos con un silanilo, su preparacion y su aplicacion en terapeutica. | |
| ATE374779T1 (de) | Phosphonium- und imidazoliumsalze und verfahren zu deren herstellung | |
| IN2006DE01793A (es) | ||
| MXPA05008450A (es) | Procesos para la preparacion de n-heteroaril-n-aril-aminas mediante reaccion de un ester de acido n-aril-carbamico con un halo-heteroarilo y procesos analogos. | |
| BRPI0408492A (pt) | processo para preparar ditioésteres | |
| TW200716518A (en) | Acetylene derivatives | |
| GB1139918A (en) | Dialkylamine derivatives, polymers produced therefrom and their use as flocculating agents | |
| WO2007016392A3 (en) | Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors | |
| RS53379B (en) | N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES AND THE PROCEDURE FOR THEIR PREPARATION | |
| EA200800502A1 (ru) | Соединения 3-аминокарбазола, фармацевтическая композиция, содержащая указанные соединения, и способ их получения | |
| JO2413B1 (en) | Benzoxazine derivatives and their use | |
| UA86013C2 (ru) | Производные арилалкилкарбаматов, их получение и применение в лечении | |
| NO20034667L (no) | Arylsulfonamider som antivirale midler | |
| DE60331586D1 (de) | Festphase fluorierung von uracil | |
| HUP0302467A2 (hu) | Eljárás szulfonamidcsoporttal szubsztituált imidazotriazinon-származékok előállítására | |
| GEP20074256B (en) | Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing | |
| NO20040388L (no) | Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten | |
| MY134437A (en) | Process for lowering level of salt required for dilution thickening | |
| HRP20010798B1 (en) | Processes for preparing pesticidal intermediates | |
| RU2008136367A (ru) | Улучшенный способ получения производных нитроизомочевины | |
| TW200606154A (en) | Mercaptoimidazoles as CCR2 receptor antagonists | |
| TW200606155A (en) | Mercaptoimidazoles as CCR2 receptor antagonists | |
| BR0311590A (pt) | Agonistas de brs-3 não-peptìdicos | |
| MXNL04000051A (es) | Proceso para la produccion de un inmunosupresor. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Application granted | ||
| FD | Application lapsed |